在一项关于NK细胞对于实体瘤杀伤作用的体外研究中,发现KIR不相合组NK对肾细胞癌和恶性黑色素瘤等细胞株的杀伤率明显高于KIR相合组[24]。而另一项关于NK细胞杀伤乳腺癌细胞株SKBR3的研究中,情况却正好相反,当供者KIR类型与SKBR3相合时,NK细胞对肿瘤的杀伤率显著高于不相合组[25]。是否提示,对于不同种类的实体瘤,其杀伤途径有差异,提示在临床应用中应当进行个体化的过继免疫治疗方式。 5 展 望
目前在KIR与配体识别机制及信号传导等方面已获得一定进展。关于抑制性受体的研究已较为深入,尤其在血液系统肿瘤治疗方面,但是,抗肿瘤是个复杂的、多种因素共同起作用的过程,是各种免疫细胞综合作用的结果。NK细胞对于各类实体瘤的杀伤过程中KIR是否都起到关键作用,还需要进一步探讨。淋巴细胞白血病、淋巴瘤对于NK细胞的杀伤就表现出高度的不敏感性,但增强NK细胞活性可以提高对ALL的杀伤率[26]。针对激活性KIR而设计的增强NK细胞杀伤活性尚在初步研究中。从激活KIR的角度出发,提高NK细胞的杀伤活性,有待在肿瘤生物治疗方面提供一条新的思路。
【参考文献】
[1] Ljunggren HG, Karre K. In search of the missing?鄄self: MHC molecules and NK cell recognition[J]. Immunol Today,1990,(11):237-244.
[2] K?覿rre K. How to recognize a foreign submarine[J]. Immunol Rev,1997,155:5-9.
[3] Smyty MC, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy[J].Nature Immunol, 2001,2:293-299.
[4] Cooper MA, Fehmiger TA. The biology of human natural killer?鄄cell subsets[J]. Trends Immunol,2001,22(11):633-640.
[5] Held W, Coudert JD, Zimmer, et al. The NK cell receptor repertoire: formation, adaptation and exploitation[J].Curr Opin Immunol,2003, 15(2):233-237.
[6] Shilling HG, Guethlein LA, Cheng NW. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype[J]. J Immunol, 2002, 168:2307-2315.
[7] Witt CS, Whiteway JM, Warren HS, et al. Alleles of the KIR2DL4 receptor and their lack of association with pre?鄄eclampsia[J]. Eur J Immunol,2002,32:18-29.
[8] Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig?鄄like receptor (KIR) haplotype analysis by gene content:evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets[J].J Immunol,2002,169: 5118-5129.
[9] Marsh SG, Parham P, Dupont B, et al. Killer cell immunoglobulin?鄄like receptor (KIR) nomenclature report[J].Eur J Immuno Genetics ,2003,30:229.
[10] 张磊,Katharine C,Dupont B,等.上海地区汉族人群杀伤细胞免疫球蛋白样受体基因多样性及单倍型组合研究[J].中华医学遗传学杂志,2003,20(5):396-399.
[11] Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity[J]. Annu Rev Immunol,2002,20 :217-251.
[12] Trowsdale J, Barten R, Haude A, et al. The genomic context of natural killer receptor extended gene families[J].Immunol Rev,2001,181:20-38.
[13] Dupont B, Hsu KC.Inhibitory killer Ig?鄄like receptor genes and human leukocyte antigen class Ⅰ ligands in haematopoietic stem cell transplantation[J].Curr Opin Immunol,2004,16(5): 634-643.
[14] Van der Merwe PA. Formation and function of the immunological synapse[J]. Curr Opin Immunol,2002,14(3): 293-298.
[15] Vyas YM, Mehta KM, Morgan M, et al. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class Ⅰ?鄄regulatednoncytolytic and cytolytic interactions[J]. J Immunol,2001 ,167(8):4358-4367.
[16] Bromley SK, Burack WR, Johnsos KG, et al. The immunological synapse[J]. Annu Rev Immunol,2000,21:375-396.
[17] Carosella ED, Paul P, Moreau P, et al. HLA?鄄G and HLA?鄄E:fundamental and pathophysiological aspects[J].Immunol Today,2000 ,21(11) :532-534.
[18] Contini P, Ghio M, Poggi A, et al. Soluble HLA?鄄A,?鄄B,?鄄C and?鄄G molecules induce apoptosis in T and NK CD8T cells and inhibit cytotoxic T cell activity through CD8 ligation[J]. Eur J Immunol,2003,33: 125-134.
[19] Voutsadakis IA. NK cells in allogeneic bone marrow transplantation [J]. Cancer Immunol, 2003,52 (9):525-534.
[20] 段连宁,陈纯,黄绍良,等.免疫活性细胞表达杀伤细胞抑制性受体与造血干细胞移植后移植物抗宿主病的关系[J].
中国实验血液学杂志,2003,11 (6) :625-632.
[21] Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002,295: 2097-2100.
[22] Schaffer M, Malmberg KJ, Ringden O, et al.Increased infection?鄄related mortality in KIR?鄄ligand?鄄mismatched unrelated allogeneic hematopoietic stem?鄄cell transplantation[J].Transplantation,2004, 78(7): 1081-1085.
[23] Roger K, Strair, Schaar D, et al. Antineoplastic effects of partially HLA?鄄matched irradiated blood mononuclear cells in patients with renal cell carcinoma[J]. J Clin Oncol, 2003,21: 3785-3791.
转贴于 酷文网-论文下载中心 http://www.coolwen.net
共3页: 上一页 [1] 2 [3] 下一页
网摘收藏: